Ocuphire Pharma Inc. Stock
Price
Target price
€1.07
€1.07
5.180%
0.054
5.180%
-
02.09.25 / Tradegate
WKN: A2QG4Z / Symbol: OCUP / Name: Ocuphire Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Ocuphire Pharma Inc. Stock
A very strong showing by Ocuphire Pharma Inc. today, with an increase of €0.054 (5.180%) compared to yesterday's price.
For the coming years our community has positive and negative things to say abot the Ocuphire Pharma Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Innovation" there were negative voices in the community.
Pros and Cons of Ocuphire Pharma Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ocuphire Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ocuphire Pharma Inc. | 5.180% | 3.282% | 15.178% | -1.292% | -3.604% | -52.822% | - |
| NanoViricides Inc. | 0.840% | -4.098% | -13.333% | -26.415% | -22.000% | -45.883% | -77.282% |
| Actinium Pharmaceuticals Inc. | -1.920% | -4.139% | 5.191% | -13.669% | 26.759% | -81.728% | -76.238% |
| Immunic Inc. | -1.470% | -7.317% | -15.031% | -45.886% | -32.344% | -85.056% | -94.347% |
Comments
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at HC Wainwright from $20.00 to $18.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at Alliance Global Partners from $24.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
